Radiprodil, a NR2B-NMDA Negative Allosteric Modulator, for GRIN-Related Disorder
Radiprodil, a NR2B-NMDA Negative Allosteric Modulator, for GRIN-Related Disorder Caused by Gain of Function Mutations: GRIN Therapeutics.
Pierandrea Muglia, MD, President & Founder, GRIN Therapeutics, Session IX: Clinical Drugs. For additional sessions, visit https://www.epilepsy.com/pipeline2022 and https://www.epilepsy.com/newsandstories.
![Непутёвый ученик в школе магии: Гость | Официальный трейлер [русские субтитры]](https://images.videosashka.com/watch/_dCIoopsewY)
